Our Team

Carl Berke, PhD

Carl’s career has spanned over 25 years in the practice and management of innovation to bring new technologies from lab to market. As a bench scientist and R&D director, he worked at Polaroid Corporation and Hygeia Sciences in the development of photographic and clinical products for both consumer and professional markets – he is an inventor on 6 US patents. He served as a Partner at Integral/Analysis Group, a consulting firm focusing on the management of innovation and growth strategy for clients in healthcare and consumer products. He has been an active private equity investor as a member of Angel Healthcare Investors LLC and is a founder of Mass Medical Angels. He has served on the boards of Quosa [research literature management software], Kasalis [robotics], Combinent [women’s health], Infobionic [cardiac monitoring], Annovation [anesthestic agent] and currently sits on the board of Syntimmune [immunotherapy], QPID Health [bioinformatics], LifeImage [diagnostic image sharing], Sebacia [dermatology therapy] and the Sudanese Education Fund [philanthropy]. Carl holds an AB degree from Cornell University and received his PhD in Organic Chemistry from the University of California at Berkeley. He also holds an appointment as Lecturer in the MIT Sloan School of Management teaching various courses on the topic of biomedical enterprise.